GLYCOGEN STORAGE DISEASE TYPE II

GLYCOGEN STORAGE DISEASE TYPE II was reported 105 times

GLYCOGEN STORAGE DISEASE TYPE II is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] 27 0.0079
1 Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] 1 0.0001
2 Antimalarial [EPC] 1 0.0001
3 Antiprotozoal [EPC] 1 0.0001
4 Catecholamine [EPC] 6 0.0001
5 Human Immunoglobulin G [EPC] 1 0.0000
6 Folate Analog Metabolic Inhibitor [EPC] 12 0.0000
7 Histamine-1 Receptor Antagonist [EPC] 2 0.0000
8 General Anesthetic [EPC] 1 0.0000
9 Aminoglycoside Antibacterial [EPC] 1 0.0000
10 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
11 Osmotic Laxative [EPC] 5 0.0000
12 HMG-CoA Reductase Inhibitor [EPC] 6 0.0000
13 Glycopeptide Antibacterial [EPC] 1 0.0000
14 Histamine-2 Receptor Antagonist [EPC] 2 0.0000
15 CD20-directed Cytolytic Antibody [EPC] 4 0.0000
16 Interleukin-12 Antagonist [EPC] 1 0.0000
17 Interleukin-23 Antagonist [EPC] 1 0.0000
18 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
19 Parathyroid Hormone Analog [EPC] 1 0.0000
20 Loop Diuretic [EPC] 4 0.0000
21 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
22 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
23 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
24 Janus Kinase Inhibitor [EPC] 1 0.0000
25 Anti-epileptic Agent [EPC] 1 0.0000
26 Nonsteroidal Anti-inflammatory Drug [EPC] 5 0.0000
27 Platinum-based Drug [EPC] 1 0.0000
28 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
29 Corticosteroid [EPC] 4 0.0000
30 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
31 GLP-1 Receptor Agonist [EPC] 1 0.0000
32 Atypical Antipsychotic [EPC] 1 0.0000
33 Benzodiazepine [EPC] 1 0.0000
34 Tumor Necrosis Factor Blocker [EPC] 1 0.0000